FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220748839> ?p ?o ?g. }

• W4220748839 abstract "Abstract Background Antiretroviral therapy (ART) through universal test and treat (UTT) and HIV pre-exposure prophylaxis (PrEP) substantially reduces HIV-related mortality, morbidity and incidence. Effective individual-level prevention modalities have not translated into population-level impact in southern Africa due to sub-optimal coverage among adolescents and youth who are hard to engage. We aim to investigate the feasibility, acceptability, and preliminary population level effectiveness of HIV prevention services with or without peer support to reduce prevalence of transmissible HIV amongst adolescents and young adults in KwaZulu-Natal. Methods We are conducting a 2 × 2 factorial trial among young men and women aged 16–29 years, randomly selected from the Africa Health Research Institute demographic surveillance area. Participants are randomly allocated to one of four intervention combinations: 1) Standard of Care (SOC): nurse-led services for HIV testing plus ART if positive or PrEP for those eligible and negative; 2) Sexual and Reproductive Health (SRH): Baseline self-collected vaginal and urine samples with study-organized clinic appointments for results, treatment and delivery of HIV testing, ART and PrEP integrated with SRH services; 3) Peer-support: Study referral of participants to a peer navigator to assess their health, social and educational needs and provide risk-informed HIV prevention, including facilitating clinic attendance; or 4) SRH + peer-support. The primary outcomes for effectiveness are: (1) the proportion of individuals with infectious HIV at 12 months and (2) uptake of risk-informed comprehensive HIV prevention services within 60 days of enrolment. At 12 months, all participants will be contacted at home and the study team will collect a dried blood spot for HIV ELISA and HIV viral load testing. Discussion This trial will enable us to understand the relative importance of SRH and peer support in creating demand for effective and risk informed biomedical HIV prevention and preliminary data on their effectiveness on reducing the prevalence of transmissible HIV amongst all adolescents and youth. Trial registration Trial Registry: clincialtrials.gov. ClinicalTrials.gov Identifier NCT04532307 . Registered: March 2020." @default.
• W4220748839 created "2022-04-03" @default.
• W4220748839 creator A5005153909 @default.
• W4220748839 creator A5017146733 @default.
• W4220748839 creator A5020093117 @default.
• W4220748839 creator A5021249576 @default.
• W4220748839 creator A5024565534 @default.
• W4220748839 creator A5031758613 @default.
• W4220748839 creator A5032466026 @default.
• W4220748839 creator A5039352840 @default.
• W4220748839 creator A5043916447 @default.
• W4220748839 creator A5046030234 @default.
• W4220748839 creator A5046238828 @default.
• W4220748839 creator A5051037765 @default.
• W4220748839 creator A5063733311 @default.
• W4220748839 creator A5068458100 @default.
• W4220748839 creator A5072872691 @default.
• W4220748839 creator A5082554238 @default.
• W4220748839 creator A5091093164 @default.
• W4220748839 creator A5091569181 @default.
• W4220748839 date "2022-03-07" @default.
• W4220748839 modified "2023-10-08" @default.
• W4220748839 title "Isisekelo Sempilo study protocol for the effectiveness of HIV prevention embedded in sexual health with or without peer navigator support (Thetha Nami) to reduce prevalence of transmissible HIV amongst adolescents and young adults in rural KwaZulu-Natal: a 2 × 2 factorial randomised controlled trial" @default.
• W4220748839 cites W1413161224 @default.
• W4220748839 cites W2093274439 @default.
• W4220748839 cites W2140083708 @default.
• W4220748839 cites W2301539856 @default.
• W4220748839 cites W2467053508 @default.
• W4220748839 cites W2548842344 @default.
• W4220748839 cites W2558953010 @default.
• W4220748839 cites W2561929915 @default.
• W4220748839 cites W2763419945 @default.
• W4220748839 cites W2775758586 @default.
• W4220748839 cites W2790824153 @default.
• W4220748839 cites W2791277534 @default.
• W4220748839 cites W2808860412 @default.
• W4220748839 cites W2811027263 @default.
• W4220748839 cites W2897190201 @default.
• W4220748839 cites W2921807763 @default.
• W4220748839 cites W2943039121 @default.
• W4220748839 cites W2945238362 @default.
• W4220748839 cites W2958150136 @default.
• W4220748839 cites W2963971399 @default.
• W4220748839 cites W2968195467 @default.
• W4220748839 cites W2982097452 @default.
• W4220748839 cites W2990321742 @default.
• W4220748839 cites W2999150894 @default.
• W4220748839 cites W2999600452 @default.
• W4220748839 cites W3016631176 @default.
• W4220748839 cites W3037885167 @default.
• W4220748839 cites W3082355087 @default.
• W4220748839 cites W3082847076 @default.
• W4220748839 cites W3087006383 @default.
• W4220748839 cites W3120591033 @default.
• W4220748839 cites W3133941207 @default.
• W4220748839 cites W3154916838 @default.
• W4220748839 cites W4212799088 @default.
• W4220748839 cites W4226082845 @default.
• W4220748839 doi "https://doi.org/10.1186/s12889-022-12796-8" @default.
• W4220748839 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35255859" @default.
• W4220748839 hasPublicationYear "2022" @default.
• W4220748839 type Work @default.
• W4220748839 citedByCount "1" @default.
• W4220748839 countsByYear W42207488392023 @default.
• W4220748839 crossrefType "journal-article" @default.
• W4220748839 hasAuthorship W4220748839A5005153909 @default.
• W4220748839 hasAuthorship W4220748839A5017146733 @default.
• W4220748839 hasAuthorship W4220748839A5020093117 @default.
• W4220748839 hasAuthorship W4220748839A5021249576 @default.
• W4220748839 hasAuthorship W4220748839A5024565534 @default.
• W4220748839 hasAuthorship W4220748839A5031758613 @default.
• W4220748839 hasAuthorship W4220748839A5032466026 @default.
• W4220748839 hasAuthorship W4220748839A5039352840 @default.
• W4220748839 hasAuthorship W4220748839A5043916447 @default.
• W4220748839 hasAuthorship W4220748839A5046030234 @default.
• W4220748839 hasAuthorship W4220748839A5046238828 @default.
• W4220748839 hasAuthorship W4220748839A5051037765 @default.
• W4220748839 hasAuthorship W4220748839A5063733311 @default.
• W4220748839 hasAuthorship W4220748839A5068458100 @default.
• W4220748839 hasAuthorship W4220748839A5072872691 @default.
• W4220748839 hasAuthorship W4220748839A5082554238 @default.
• W4220748839 hasAuthorship W4220748839A5091093164 @default.
• W4220748839 hasAuthorship W4220748839A5091569181 @default.
• W4220748839 hasBestOaLocation W42207488391 @default.
• W4220748839 hasConcept C118552586 @default.
• W4220748839 hasConcept C121752807 @default.
• W4220748839 hasConcept C138816342 @default.
• W4220748839 hasConcept C140556311 @default.
• W4220748839 hasConcept C159110408 @default.
• W4220748839 hasConcept C162324750 @default.
• W4220748839 hasConcept C205545832 @default.
• W4220748839 hasConcept C27415008 @default.
• W4220748839 hasConcept C2776135927 @default.
• W4220748839 hasConcept C2776939746 @default.
• W4220748839 hasConcept C2776983459 @default.
• W4220748839 hasConcept C2778173179 @default.
• W4220748839 hasConcept C2779496540 @default.
• W4220748839 hasConcept C2781094116 @default.
• W4220748839 hasConcept C2908647359 @default.
• W4220748839 hasConcept C3013748606 @default.

• next